251 related articles for article (PubMed ID: 24499991)
1. Combined hormonal contraception and risk of venous thromboembolism within the first year following pregnancy. Danish nationwide historical cohort 1995-2009.
Petersen JF; Bergholt T; Nielsen AK; Paidas MJ; Løkkegaard EC
Thromb Haemost; 2014 Jul; 112(1):73-8. PubMed ID: 24499991
[TBL] [Abstract][Full Text] [Related]
2. Low risk of venous thromboembolism following early pregnancy loss in pregnancies conceived by IVF.
Hansen AT; Juul S; Knudsen UB; Hvas AM
Hum Reprod; 2018 Oct; 33(10):1968-1972. PubMed ID: 30137318
[TBL] [Abstract][Full Text] [Related]
3. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study.
Le Moigne E; Delluc A; Tromeur C; Nowak E; Mottier D; Lacut K; Le Gal G
Thromb Res; 2013 Jul; 132(1):51-5. PubMed ID: 23786893
[TBL] [Abstract][Full Text] [Related]
4. Hormonal contraceptives and venous thromboembolism: an epidemiological update.
Plu-Bureau G; Maitrot-Mantelet L; Hugon-Rodin J; Canonico M
Best Pract Res Clin Endocrinol Metab; 2013 Feb; 27(1):25-34. PubMed ID: 23384743
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism in pregnancy and the puerperal period: a study of 1210 events.
Virkus RA; Løkkegaard EC; Lidegaard Ø; Langhoff-Roos J; Bjerregaard L; Skovlund CW; Bergholt T
Acta Obstet Gynecol Scand; 2013 Oct; 92(10):1135-42. PubMed ID: 23869667
[TBL] [Abstract][Full Text] [Related]
6. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism in pregnant and puerperal women in Denmark 1995-2005. A national cohort study.
Virkus RA; Løkkegaard EC; Bergholt T; Mogensen U; Langhoff-Roos J; Lidegaard Ø
Thromb Haemost; 2011 Aug; 106(2):304-9. PubMed ID: 21713323
[TBL] [Abstract][Full Text] [Related]
8. Hormonal contraception and risk of venous thromboembolism: national follow-up study.
Lidegaard Ø; Løkkegaard E; Svendsen AL; Agger C
BMJ; 2009 Aug; 339():b2890. PubMed ID: 19679613
[TBL] [Abstract][Full Text] [Related]
9. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.
Lidegaard Ø; Nielsen LH; Skovlund CW; Skjeldestad FE; Løkkegaard E
BMJ; 2011 Oct; 343():d6423. PubMed ID: 22027398
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of hormonal contraceptives-related venous thromboembolism.
Hugon-Rodin J; Gompel A; Plu-Bureau G
Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic risks of oral contraceptives.
Rott H
Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
[TBL] [Abstract][Full Text] [Related]
12. Hormonal contraception and venous thromboembolism.
Lidegaard Ø; Milsom I; Geirsson RT; Skjeldestad FE
Acta Obstet Gynecol Scand; 2012 Jul; 91(7):769-78. PubMed ID: 22568831
[TBL] [Abstract][Full Text] [Related]
13. [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].
Plu-Bureau G; Horellou MH; Gompel A; Conard J
Gynecol Obstet Fertil; 2008 Apr; 36(4):448-54. PubMed ID: 18424163
[TBL] [Abstract][Full Text] [Related]
14. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of contraceptive methods during the postpartum period.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):878-83. PubMed ID: 21734635
[TBL] [Abstract][Full Text] [Related]
15. SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update.
Reid R;
J Obstet Gynaecol Can; 2010 Dec; 32(12):1192-1197. PubMed ID: 21176332
[TBL] [Abstract][Full Text] [Related]
16. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.
Le Gal G; Kovacs MJ; Carrier M; Do K; Kahn SR; Wells PS; Anderson DA; Chagnon I; Solymoss S; Crowther M; Righini M; Lacut K; White RH; Vickars L; Rodger M
Thromb Haemost; 2010 Sep; 104(3):498-503. PubMed ID: 20539910
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease and venous thromboembolism during pregnancy and the postpartum period.
Hansen AT; Erichsen R; Horváth-Puhó E; Sørensen HT
J Thromb Haemost; 2017 Apr; 15(4):702-708. PubMed ID: 28135041
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism in women taking hormonal contraceptives.
Blanco-Molina A; Monreal M
Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):211-5. PubMed ID: 20136607
[TBL] [Abstract][Full Text] [Related]
19. Risks of thromboembolism associated with hormonal contraceptives related to body mass index and aging in Japanese women.
Sugiura K; Kobayashi T; Ojima T
Thromb Res; 2016 Jan; 137():11-16. PubMed ID: 26672897
[TBL] [Abstract][Full Text] [Related]
20. Does the Progestogen Used in Combined Hormonal Contraception Affect Venous Thrombosis Risk?
Han L; Jensen JT
Obstet Gynecol Clin North Am; 2015 Dec; 42(4):683-98. PubMed ID: 26598309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
